QNCX ▲ +2.5% - Quince Therapeutics, Inc. $QNCX - Quince Therapeutics to Host Virtual KOL Event to Discuss the Current Treatment Landscape for PH-ILD and BOS and the Role for LAM-001 as a Potential Therapeutic Option on September 28, 2026 Quince Therapeutics rose 2.5% after announcing it will host a virtual key opinion leader event on September 28, 2026, to discuss its LAM-001 candidate as a potential treatment for pulmonary hypertension associated with interstitial lung disease (PH-ILD) and bronchiolitis obliterans syndrome (BOS). The event signals the company's continued clinical development of the program and its effort to build support among influential physicians in the space. 17-SEP-2026 08:00 AM ET